Journal
PSYCHIATRY RESEARCH
Volume 186, Issue 1, Pages 133-137Publisher
ELSEVIER IRELAND LTD
DOI: 10.1016/j.psychres.2010.06.023
Keywords
Major depressive disorder; Remission; Social and occupational functioning
Categories
Funding
- Eli Lilly and Company
Ask authors/readers for more resources
The main goal in the treatment of major depressive disorder (MDD) is to achieve remission, defined as the resolution of symptoms and the return to normal levels of functionality. However, the clinical assessment of remission is usually merely based on scores of symptomatic rating scales. One of the most widely used scales to measure remission is the HAM-D-17, in which remission is defined as a score <= 7. Nevertheless, several studies have shown that this cutoff could be too high when also functioning is considered. This is a post-hoc analysis of a 6-month prospective study, performed over a sample of 292 Spanish patients with MDD, in order to find the optimal cutoff in the HAM-D17 scale, considering normal levels of functionality, evaluated by the SOFAS: by means of plotting Receiver Operating Characteristics (ROC) curves. Our results show that a score of <= 5 maximized both sensitivity and specificity for identifying normal levels of functionality with respect to other scores, and thus agree with previous works, which suggest that a cutoff <= 7 might be too high to consider remission in patients with MDD, when normal levels of functioning are taken into account. (C) 2010 Elsevier Ireland Ltd. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available